Bank of New Hampshire Purchases 8,281 Shares of SPDR S&P Biotech ETF $XBI

Bank of New Hampshire increased its position in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) by 95.4% during the 3rd quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 16,961 shares of the exchange traded fund’s stock after buying an additional 8,281 shares during the quarter. Bank of New Hampshire’s holdings in SPDR S&P Biotech ETF were worth $2,674,000 at the end of the most recent reporting period.

A number of other institutional investors have also made changes to their positions in XBI. Compound Planning Inc. lifted its stake in SPDR S&P Biotech ETF by 0.7% during the first quarter. Compound Planning Inc. now owns 10,889 shares of the exchange traded fund’s stock worth $1,391,000 after purchasing an additional 75 shares in the last quarter. PeakShares LLC lifted its stake in SPDR S&P Biotech ETF by 5.2% in the first quarter. PeakShares LLC now owns 1,684 shares of the exchange traded fund’s stock worth $215,000 after acquiring an additional 84 shares during the last quarter. Centaurus Financial Inc. increased its holdings in SPDR S&P Biotech ETF by 11.4% in the first quarter. Centaurus Financial Inc. now owns 1,254 shares of the exchange traded fund’s stock valued at $160,000 after buying an additional 128 shares during the last quarter. First Heartland Consultants Inc. raised its position in shares of SPDR S&P Biotech ETF by 1.3% during the 2nd quarter. First Heartland Consultants Inc. now owns 9,709 shares of the exchange traded fund’s stock worth $1,536,000 after acquiring an additional 128 shares in the last quarter. Finally, Tranquilli Financial Advisor LLC grew its position in shares of SPDR S&P Biotech ETF by 5.4% in the 2nd quarter. Tranquilli Financial Advisor LLC now owns 2,926 shares of the exchange traded fund’s stock valued at $463,000 after buying an additional 150 shares during the last quarter.

SPDR S&P Biotech ETF Trading Down 3.4%

Shares of SPDR S&P Biotech ETF stock traded down $5.29 on Tuesday, hitting $150.90. The stock had a trading volume of 17,219,941 shares, compared to its average volume of 9,131,324. SPDR S&P Biotech ETF has a 52-week low of $102.55 and a 52-week high of $169.89. The company’s 50 day moving average price is $158.43 and its 200 day moving average price is $145.30. The stock has a market cap of $9.91 billion, a price-to-earnings ratio of 11.47 and a beta of 0.83.

SPDR S&P Biotech ETF Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Biotech Index is a modified equal weight index.